PLUR Stock - Pluri Inc.

PLUR Stock Chart

PLUR Profile

Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.

PLUR Revenue Chart

PLUR Earnings